台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股▼0.22%
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
旭富 (4119)籌碼相關-元大-太平 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-太平 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/26191.2000.0091.0012500.40%
2024/12/16590.2000.0090.3052422.06%
2024/12/09294.90394.0393.40-1224-0.44%
2024/12/06197.5000.0097.0012200.45%
2024/12/03197.60298.2097.80-1216-0.46%
2024/11/20197.90198.4097.8001720.00%
2024/11/14195.8000.0094.9011420.70%
2024/11/13395.73495.6896.00-1136-0.73%
2024/11/1200.00294.3094.30-2123-1.62%
2024/11/11194.40193.4093.3001120.00%
2024/11/0100.00189.9090.00-1114-0.87%
2024/10/1100.00291.1091.00-2133-1.50%
2024/09/1600.001.487.6087.80-1.4152-0.89%
2024/09/0400.00287.0087.00-2165-1.21%
2024/09/0300.00288.4088.50-2164-1.22%
2024/09/0200.00188.4088.50-1168-0.59%
2024/08/2900.00288.1088.50-2172-1.16%
2024/07/2200.00690.7090.80-6202-2.96%
2024/07/1500.000.192.6092.80-0.1202-0.05%
2024/07/0400.00691.2091.20-6205-2.92%
2024/06/130.190.2000.0090.000.12120.05%
2024/06/11691.3000.0090.2062142.80%
2024/06/07392.50492.7393.10-1216-0.46%
2024/06/05392.7300.0092.9032201.36%
2024/06/0400.00292.3092.50-2228-0.88%
2024/05/28492.6800.0092.5042351.70%
2024/05/20194.1000.0093.4012330.43%
2024/05/17193.20193.7093.9002300.00%
2024/05/1500.00191.7091.50-1222-0.45%
2024/05/10390.4700.0090.9032401.25%
2024/05/09388.9000.0088.5032431.23%
2024/04/190.187.09185.8086.40-0.9254-0.35%
2024/04/10189.6000.0089.5012610.38%
2024/03/26487.6000.0087.2042601.54%
2024/03/2200.001.187.3387.60-1.1265-0.41%
2024/03/180.487.0300.0086.900.42840.14%
2024/03/13587.98187.9087.9042851.40%
2024/03/1200.000.589.4089.00-0.5278-0.18%
2024/03/11189.3000.0089.1012750.36%
2024/03/07190.6000.0090.5012690.37%
2024/03/0100.00191.7091.40-1274-0.36%
2024/02/26291.2000.0092.1022830.71%
2024/02/220.591.7000.0091.300.52830.18%
2024/02/200.191.10290.9091.00-1.9284-0.68%
2024/02/01192.2000.0092.3012990.33%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章